💬In plain words
What the trial is, and whether it could suit you
The objective of the study is to evaluate the performance of muscle ultrasound sections on antenatal ultrasound between 21-24 amenorrhea weeks for the screening of muscle atrophy, in a sample of low-risk and high-risk pregnancies of congenital multiple arthrogryposis
Sign in to get the eligibility rules as simple questions to take to your doctor.
📋 Eligibility rules (as published)
Inclusion Criteria:
* Any pregnant woman consulting in one of the two obstetric gynecology departments in connection with the CPDPN (Multidisciplinary Prenatal Diagnostic Centers) of the University hospitals of Lyon or Grenoble.
* Mono-embryonic pregnancy.
* Gestational ages retained on the first dating ultrasound or the 1st trimester ultrasound between 21-24 amenorrhea weeks.
* For women at "high risk": diagnosis during ultrasound of the 1st, 2nd, or 3rd trimesters, of an abnormality of position / deformation of one or more joints, and / or an abnormality of fetal movements on screening ultrasound or interrogation (population group at "high risk of AMC").
* Regulatory criteria: adults, affiliated to a social security scheme, having signed a consent
Exclusion Criteria:
* Multiple pregnancies, and / or non-progressive .
* Obese women (BMI \> 30 in early pregnancy)
* Subject in a period of exclusion from another study
* Subject under administrative or judicial supervision
* Subject who cannot be contacted in case of emergency
💊
What it tests
- ultrasound muscle imaging technique
university hospital of Grenoble
La Tronche, France
Hopitaux Civils de Lyon - Hôpital Femme Mère Enfant
Bron, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
HealthTeky